Pharmacogenetics and Depression: A Critical Perspective
Filippo Corponi, Chiara Fabbri, Alessandro Serretti
Psychiatry Investig. 2019;16(9):645-653.   Published online 2019 Aug 29     DOI: https://doi.org/10.30773/pi.2019.06.16
Effectiveness of pharmacogenomic tests including CYP2D6 and CYP2C19 genomic variants for guiding the treatment of depressive disorders: Systematic review and meta-analysis of randomised controlled trials
Danilo Arnone, Omar Omar, Teresa Arora, Linda Östlundh, Reshma Ramaraj, Syed Javaid, Romona Devi Govender, Bassam R. Ali, George P. Patrinos, Allan H. Young, Emmanuel Stip
Neuroscience & Biobehavioral Reviews.2023; 144: 104965.     CrossRef
Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence
Di Fu, Hong-Li Guo, Ya-Hui Hu, Wei-Rong Fang, Qian-Qi Liu, Jing Xu, Dan-Dan Wu, Feng Chen
European Journal of Clinical Pharmacology.2023;[Epub]     CrossRef
Commentary on ‘Perspectives on the Clinical Use of Pharmacogenetic Testing in Late-Life Mental Healthcare: A Survey of the American Association of Geriatric Psychiatry Membership’
Parnika Prashasti Saxena
The American Journal of Geriatric Psychiatry.2022; 30(5): 572.     CrossRef
The Utility of Pharmacogenetic-Guided Psychotropic Medication Selection for Pediatric Patients: A Retrospective Study
Merlin Ariefdjohan, Yee Ming Lee, Danielle L. Stutzman, Sean LeNoue, Marianne Z. Wamboldt
Pediatric Reports.2021; 13(3): 421.     CrossRef
Genetic Variations Associated with Long-Term Treatment Response in Bipolar Depression
Gerard Anmella, Silvia Vilches, Jordi Espadaler-Mazo, Andrea Murru, Isabella Pacchiarotti, Miquel Tuson, Marina Garriga, Eva Solé, Mercè Brat, Giovanna Fico, Eduard Vieta
Genes.2021; 12(8): 1259.     CrossRef
Economic Impact of the Application of a Precision Medicine Model (5SPM) on Psychotic Patients
Lorena Carrascal-Laso, Manuel Ángel Franco-Martín, Elena Marcos-Vadillo, Ignacio Ramos-Gallego, Belén García-Berrocal, Eduardo Mayor-Toranzo, Santiago Sánchez-Iglesias, Carolina Lorenzo, Alfonso Sevillano-Jiménez, Almudena Sánchez-Martín, María Jesús Garc
Pharmacogenomics and Personalized Medicine.2021; Volume 14: 1015.     CrossRef
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial)
Alessandra Minelli, Stefano Barlati, Erika Vitali, Stefano Bignotti, Vincenzo Dattilo, Giovanni Battista Tura, Elisabetta Maffioletti, Edoardo Giacopuzzi, Vincenza Santoro, Giulia Perusi, Chiara Cobelli, Chiara Magri, Silvia Bonizzato, Luisella Bocchio-Ch
Trials.2021;[Epub]     CrossRef
Pharmacogenomic testing and antidepressant response: problems and promises
Tawny L. Smith, Charles B. Nemeroff
Brazilian Journal of Psychiatry.2020; 42(2): 116.     CrossRef
The clinical utility of combinatorial pharmacogenomic testing for patients with depression: a meta-analysis
Lisa Brown, Oliver Vranjkovic, James Li, Kunbo Yu, Talal Al Habbab, Holly Johnson, Krystal Brown, Michael R Jablonski, Bryan Dechairo
Pharmacogenomics.2020; 21(8): 559.     CrossRef
Genetic Markers for Later Remission in Response to Early Improvement of Antidepressants
Hee-Ju Kang, Ki-Tae Kim, Kyung-Hun Yoo, Yoomi Park, Ju-Wan Kim, Sung-Wan Kim, Il-Seon Shin, Ju Han Kim, Jae-Min Kim
International Journal of Molecular Sciences.2020; 21(14): 4884.     CrossRef
Mechanisms of cancer stem cell therapy
Ali Akbar Samadani, Arman Keymoradzdeh, Shima Shams, Armin Soleymanpour, Seyedeh Elham Norollahi, Sogand Vahidi, Ali Rashidy-Pour, Ali Ashraf, Ebrahim Mirzajani, Korosh Khanaki, Morteza Rahbar Taramsari, Sedigheh Samimian, Akram Najafzadeh
Clinica Chimica Acta.2020; 510: 581.     CrossRef
Primary care and mental health providers’ perceptions of implementation of pharmacogenetics testing for depression prescribing
Bonnie M. Vest, Laura O. Wray, Laura A. Brady, Michael E. Thase, Gregory P. Beehler, Sara R. Chapman, Leland E. Hull, David W. Oslin
BMC Psychiatry.2020;[Epub]     CrossRef
Contemporary Issues in Depressive Disorders
Seon-Cheol Park, Yong-Ku Kim
Psychiatry Investigation.2019; 16(9): 633.     CrossRef